These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27591148)

  • 41. Autoantibodies in lupus: culprits or passive bystanders?
    Rekvig OP; Putterman C; Casu C; Gao HX; Ghirardello A; Mortensen ES; Tincani A; Doria A
    Autoimmun Rev; 2012 Jun; 11(8):596-603. PubMed ID: 22041579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases.
    Krebs CF; Panzer U
    J Autoimmun; 2018 Feb; 87():61-68. PubMed ID: 29275837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A monoclonal antibody against CD86 and its protection in a murine lupus nephritis model of chronic graft-versus-host disease.
    Han L; Shen L; Zhu Y; Qiu Y
    Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):285-291. PubMed ID: 28747139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms.
    Yung S; Chan TM
    Autoimmun Rev; 2008 Feb; 7(4):317-21. PubMed ID: 18295737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pauci-immune and immune glomerular lesions in kidney transplants for systemic lupus erythematosus.
    Meehan SM; Chang A; Khurana A; Baliga R; Kadambi PV; Javaid B
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1469-78. PubMed ID: 18562595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lupus nephritis. How latest insights into its pathogenesis promote novel therapies.
    Kulkarni OP; Anders HJ
    Curr Opin Rheumatol; 2012 Sep; 24(5):457-65. PubMed ID: 22810362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pepsin digestion of immune complexes deposited in lupus glomeruli].
    Ikeda M; Mizoguchi Y; Kano S; Okudaira K
    Ryumachi; 1987 Feb; 27(1):2-9. PubMed ID: 3116680
    [No Abstract]   [Full Text] [Related]  

  • 49. Mechanisms of tissue injury in lupus nephritis.
    Nowling TK; Gilkeson GS
    Arthritis Res Ther; 2011; 13(6):250. PubMed ID: 22192660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating levels of chromatin fragments are inversely correlated with anti-dsDNA antibody levels in human and murine systemic lupus erythematosus.
    Jørgensen MH; Rekvig OP; Jacobsen RS; Jacobsen S; Fenton KA
    Immunol Lett; 2011 Aug; 138(2):179-86. PubMed ID: 21530588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies.
    Lefkowith JB; Gilkeson GS
    Arthritis Rheum; 1996 Jun; 39(6):894-903. PubMed ID: 8651982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amelioration of lupus nephritis by serum amyloid P component gene therapy with distinct mechanisms varied from different stage of the disease.
    Zhang W; Wu J; Qiao B; Xu W; Xiong S
    PLoS One; 2011; 6(7):e22659. PubMed ID: 21799927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of mast cell-deficient W/Wv mice to pristane-induced experimental lupus nephritis.
    Lin L; Gerth AJ; Peng SL
    Immunol Lett; 2004 Feb; 91(2-3):93-7. PubMed ID: 15019275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of anti-DNA antibodies in lupus nephritis.
    Waer M
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):111-4. PubMed ID: 2203589
    [No Abstract]   [Full Text] [Related]  

  • 55. UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?
    Cui JH; Xie X
    Inflammation; 2017 Apr; 40(2):657-665. PubMed ID: 28116572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis.
    Hong S; Healy H; Kassianos AJ
    Front Immunol; 2020; 11():578952. PubMed ID: 33072122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-dsDNA antibodies and resident renal cells - Their putative roles in pathogenesis of renal lesions in lupus nephritis.
    Yung S; Chan TM
    Clin Immunol; 2017 Dec; 185():40-50. PubMed ID: 27612436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis.
    Bagavant H; Tung KS
    J Immunol; 2005 Jul; 175(2):944-50. PubMed ID: 16002693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.
    Corradetti C; Jog NR; Cesaroni M; Madaio M; Caricchio R
    J Immunol; 2018 Jan; 200(2):512-522. PubMed ID: 29237779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of immune complex-derived anti-DNA antibodies associated with lupus nephritis.
    Sasaki T; Hatakeyama A; Shibata S; Osaki H; Suzuki M; Horie K; Kitagawa Y; Yoshinaga K
    Kidney Int; 1991 Apr; 39(4):746-53. PubMed ID: 2051733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.